NCT04510129 - A Multicenter Cancer Biospecimen Collection Study | Biotech Hunter

Enrollment

1,650

Participants

Timeline

Start Date

February 5, 2020

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions

Cancer of Head and NeckLung Cancer, Nonsmall CellSmall-cell Lung CancerUrothelial CarcinomaGastroesophageal Junction AdenocarcinomaCervical CancerEsophageal Squamous Cell CarcinomaTriple Negative Breast CancerHepatocellular CarcinomaRenal Cell CarcinomaColorectal Cancer

Interventions

DIAGNOSTIC_TEST

OncoPrism™ assay

OncoPrism™ is a new approach to characterizing the immune component of pre-treatment tumor tissue.

Trial Locations (1)

94131

RECRUITING

Curebase, San Francisco